We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HDBFS:NSEHDB Financial Services Limited Analysis

Data as of 2026-03-14 - not real-time

₹642.55

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

HDB Financial Services is trading at ₹642.55, barely above its 30‑day support of ₹640.30 and well below its 20‑day (₹694.21), 50‑day (₹718.60) and 200‑day (₹751.92) moving averages, indicating a pronounced bearish bias. The RSI of 26 signals oversold conditions, yet the MACD remains bearish with the line under the signal, and the price is trending lower on increasing volume, reinforcing short‑term downside pressure. On the fundamentals side, revenue grew 21% year‑over‑year and gross margins sit near 100%, but the company carries an extreme debt‑to‑equity ratio of 468, negligible operating cash flow and zero free cash flow, while the PE of 22.9 sits well above the industry average of 16.4, suggesting the stock is overvalued on a relative basis. Forward PE narrows to 16.4 and the upside potential of ~29% versus a 25% recent drawdown offers a modest catalyst, but the low dividend yield (0.62%) and minimal payout ratio raise questions on dividend sustainability. Overall, the blend of strong top‑line growth, heavy leverage, bearish technicals and a market sentiment leaning toward greed (Fear‑Greed Index 72.9) points to a cautious stance with limited short‑term upside.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and low RSI indicating continued weakness
  • Proximity to strong support with limited cushion

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Robust revenue growth and near‑100% gross margin
  • Forward PE aligns with industry average
  • High leverage may constrain earnings expansion

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Potential for debt restructuring given parent bank backing
  • Sustained earnings growth outlook
  • Undervalued upside relative to long‑term target price

Key Metrics & Analysis

Financial Health

Revenue Growth21.20%
Profit Margin27.59%
P/E Ratio22.9
Debt/Equity468.27
P/B Ratio2.8
Industry P/E16.4

Technical Analysis

TrendBearish
RSI26.4
Support₹640.30
Resistance₹731.30
MA 20₹694.21
MA 50₹718.60
MA 200₹751.92
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price₹828.15
Upside/Downside28.89%
GradeOvervalued
TypeBlend
Dividend Yield0.62%

Risk Assessment

Beta0.45
Volatility20.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.